Article Figures & Data
Figures
- Figure 1.
Clinical Variablesa; OUD = Opioid Use Disorder; UD = Use Disorder; aAll categories p < .001.
- Figure 2.
Mean TCU-DSa; TCU-DS = Texas Christian University Drug Screen; OUD = Opioid Use Disorder; UD = Use Disorder; ap < .001.
- Figure 3.
Buprenorphine Dosage Frequencies on December 31, 2019 in the NJDOC.
- Figure 4.
Substance-Related Institutional Chargesa, TCU-DS = Texas Christian University Drug Screen, OUD = Opioid Use Disorder; UD = Use Disorder, aAll Categories p < .001
Tables
OUD and Buprenorphine (n = 875) OUD without Buprenorphine (n = 396) No OUD (n = 367) Mental health rostera 48.4%b 33.6% 16.1% Average TCU-DSa 8.2c 6.1c 1.5c % > 3 substancesa 49.4%b 53.5%b 6.5% Stimulant UDa 45.9%b 31.1% 11.2% Cannabis UDa 45.8% 59.1%b 33.5% Alcohol UDa 31.4% 37.9%b 19.3% Sedative UDa 17.9%b 18.9%b 2.5% Hallucinogen UDa 9.3% 11.1%b 2.5% Phencyclidine UD 2.2% 2.3% 1.4% Other UD 0.5% 0.8% 0.3% OUD and Buprenorphine (n = 875) OUD without Buprenorphine (n = 396) No OUD (n = 367) Years remaining on sentencea 2.1c 3.1c 4.9c Any substance-related chargea 25.3%b 7.6% 3.3% Misuse of authorized medicationa 10.1%b 1.3% 0.5% Use of prohibited substancesa 9.0%b 1.8% 0.8% Possession of prohibited substancesa 8.5%b 3.8% 1.9% Refusing testinga 2.3%b 0.0% 0.0% Being intoxicated 1.3% 1.8% 0.3% Making intoxicants 0.7% 0.5% 0.0% Distribution of prohibited substances 0.2% 0.0% 0.0% # % Liver enzymes/disease 44 50.0% Side effects from buprenorphine-naloxone 23 26.1% No reason given 17 19.3% Patient preference 3 3.4% Refused buprenorphine-naloxone 1 1.1% # % Side effects 7 43.8% Release related 3 18.8% Refused/did not want 3 18.8% Prefers methadone 1 6.3% Disagreement about dosing 1 6.3% Misuse 1 6.3%
